Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments

Area of Science:

• Pharmacology
• Neurobiology
• Pain Management

Background:

• Oxycodone, a semisynthetic opioid derived from thebaine, has been used therapeutically for over a century.
• Early concerns regarding its abuse potential were noted as early as the 1940s.
• Despite structural similarities to morphine, oxycodone exhibits distinct pharmacological and neurobiological properties.

Purpose of the Study:

• To provide a comprehensive review of oxycodone's pharmacology and clinical applications.
• To analyze preclinical and clinical studies on oxycodone's analgesic efficacy and abuse liability.
• To explore recent advancements in identifying novel opioid analgesics with reduced abuse potential.

Main Methods:

• Review of existing literature on oxycodone's synthesis, pharmacological actions, and therapeutic use.
• Analysis of preclinical animal studies investigating analgesic effects and abuse liability.
• Examination of clinical studies and human volunteer data on subjective effects and abuse potential.

Main Results:

• Oxycodone is a μ-opioid receptor agonist with established analgesic efficacy for various pain types.
• Extensive research confirms significant abuse liability, contributing to the opioid crisis.
• Studies reveal unique pharmacological and neurobiological characteristics differentiating it from morphine.

Conclusions:

• Oxycodone remains a crucial analgesic but its high abuse potential requires careful management and the development of safer alternatives.
• Understanding its detailed pharmacology and neurobiology is key to designing future analgesics.
• Continued research into non-addictive pain relief strategies is paramount.